{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:02Z","timestamp":1786650062097,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aim of Study:<\/jats:title>\n                    <jats:p>\n                      While using F-18 fluorodeoxyglucose (FDG) positron emission tomography computed tomography (PET\/CT) for other than thyroid disease, an increased frequency of incidentally discovered areas of focally or diffuse increased uptake within the thyroid gland can be seen. We aimed to find the focal thyroid FDG uptake and compare the maximum standardized uptake value (SUV\n                      <jats:sub>max<\/jats:sub>\n                      ) results with cytology and histology results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We examined PET scan reports for all patients undergoing FDG PET\/CT investigation over a 10-year period in a single center. Twelve thousand seven hundred and ninety-six patients underwent FDG PET\/CT scanning in one PET\/CT unit. Within this group, 526 patients had diffuse, focal, or multifocal FDG uptake. About 305 of 526 patients (57.9%) showed diffuse FDG uptake and 221 (42%) showed focal uptake on thyroid gland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The malignant group thyroid nodule sizes were between 8 and 39 mm (21.1 mm average, standard deviation [SD] \u00b17.3) on ultrasonography (USG) examination. These nodules have SUV\n                      <jats:sub>max<\/jats:sub>\n                      values between 2.3 and 31.2 (average 8.8 SD \u00b1 5.7). Benign group thyroid nodule sizes were between 5 and 46 mm (average 18.3 mm, SD \u00b1 5.8) on USG examination. There were no significant correlations between SUV\n                      <jats:sub>max<\/jats:sub>\n                      of the incidental focal thyroid lesions seen on FDG PET\/CT and fine needle aspiration biopsy results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is a relatively high possibility of a malignant lesion in thyroid incidentaloma. FDG uptake of these lesions is not a useful tool in absolute discrimination between malignancy and benign lesion. The presence of primary or secondary malign lesion is diagnosed in 34.1% of the patients who are found to have incidental focal FDG uptake within thyroid gland in PET\/CT scans, but we suggest that the thyroid incidentalomas detected on FDG PET\/CT should be further examined with USG and scintigraphy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-1482.187247","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T09:03:38Z","timestamp":1531991018000},"page":"989-993","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography\/computed tomography"],"prefix":"10.4103","volume":"14","author":[{"given":"Sait","family":"Sager","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"Vatankulu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur Erdem","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferahnaz","family":"C\u0131naral","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lebriz","family":"Uslu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Baran","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerim","family":"S\u00f6nmezoglu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(00)00257-6","article-title":"Clinical role of positron emission tomography in oncology","volume":"2","author":"Bomanji","year":"2001","journal-title":"Lancet Oncol"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s002590050493","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study","volume":"26","author":"Gr\u00fcnwald","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MNM.0000000000000026","article-title":"Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: A systematic review and meta-analysis","volume":"35","author":"Chu","year":"2014","journal-title":"Nucl Med Commun"},{"key":"R4-20260109","first-page":"1431","article-title":"Understanding the standardized uptake value, its methods, and implications for usage","volume":"45","author":"Thie","year":"2004","journal-title":"J Nucl Med"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/105072502760339307","article-title":"Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: An immunohistochemical study","volume":"12","author":"Sch\u00f6nberger","year":"2002","journal-title":"Thyroid"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.crad.2011.08.005","article-title":"The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas","volume":"66","author":"Hsiao","year":"2011","journal-title":"Clin Radiol"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.carj.2011.04.003","article-title":"Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: Incidence, malignancy risk, and comparison of standardized uptake values","volume":"63","author":"Kao","year":"2012","journal-title":"Can Assoc Radiol J"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/MNM.0b013e32832ee09d","article-title":"Systematic review: Prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography","volume":"30","author":"Shie","year":"2009","journal-title":"Nucl Med Commun"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2265.2011.04107.x","article-title":"Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET\/CT): Clinical and pathological relevance","volume":"75","author":"Pagano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/01.MLG.0000163098.01398.79","article-title":"18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: High prevalence of malignancy in thyroid PET incidentaloma","volume":"115","author":"Kim","year":"2005","journal-title":"Laryngoscope"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3174\/ajnr.A1559","article-title":"The significance and management of incidental [18F] fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer","volume":"30","author":"Eloy","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MNM.0b013e328324b431","article-title":"Evaluation of thyroid FDG uptake incidentally identified on FDG-PET\/CT imaging","volume":"30","author":"Chen","year":"2009","journal-title":"Nucl Med Commun"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/RLU.0b013e31829b2686","article-title":"Is 18F-FDG PET\/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis","volume":"38","author":"Nakadate","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2967\/jnumed.106.039024","article-title":"Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland","volume":"48","author":"Karantanis","year":"2007","journal-title":"J Nucl Med"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/thy.1998.8.765","article-title":"Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography","volume":"8","author":"Boerner","year":"1998","journal-title":"Thyroid"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1067\/msy.2003.71","article-title":"Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area","volume":"133","author":"Kresnik","year":"2003","journal-title":"Surgery"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.surg.2005.08.031","article-title":"Preoperative evaluation of thyroid nodules with 18FDG-PET\/CT","volume":"138","author":"Mitchell","year":"2005","journal-title":"Surgery"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/jc.2006-2311","article-title":"18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm","volume":"92","author":"Kim","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1245\/s10434-006-9181-y","article-title":"FDG-PET detected thyroid incidentalomas: Need for further investigation?","volume":"14","author":"Are","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MNM.0b013e3280964eae","article-title":"The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT","volume":"28","author":"Bogsrud","year":"2007","journal-title":"Nucl Med Commun"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1067\/msy.2001.118265","article-title":"Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography","volume":"130","author":"Cohen","year":"2001","journal-title":"Surgery"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1210\/jc.2003-030465","article-title":"Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects","volume":"88","author":"Kang","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<574::AID-CNCR21>3.0.CO;2-#","article-title":"Metastasis to the thyroid gland. A report of 43 cases","volume":"79","author":"Nakhjavani","year":"1997","journal-title":"Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814050-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:37Z","timestamp":1786647697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814050-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.187247","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}